Parkinson's

Montreal, Quebec and Vancouver, British Columbia – Working together to accelerate research into neurological diseases, three leading players in Canada’s health sciences sector are joining forces in a unique multi-million dollar partnership to create a novel drug development platform that will help advance new therapeutics for some of the most debilitating conditions such as amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, and Parkinson’s disease.

Classified as: Parkinson's, Merck, drug development, CDRD
Published on: 16 Mar 2017

CQDM and Brain Canada join forces again in the funding of two new research projects to address unmet needs in brain research

CQDM and Brain Canada are proud to announce the funding of two new multi-disciplinary and multi-institutional research projects under the second edition of their Focus on Brain strategic initiative. The partners will award a total of $3M to two research teams to develop cutting-edge tools, technologies and platforms designed to accelerate the discovery of new drugs for brain and nervous system disorders.

Classified as: Parkinson's, Ted Fon, ALS, Brain Canada, Canada Brain Research Fund, CQDM, Fon, Edward Fon
Published on: 2 Feb 2017

A team of scientists led by Dr. Michel Desjardins from the University of Montreal and Dr. Heidi McBride from the Montreal Neurological Institute and Hospital (MNI) at McGill University have discovered that two genes associated with Parkinson's disease (PD) are key regulators of the immune system, providing direct evidence linking Parkinson's to autoimmune disease.

Using both cellular and mouse models, the team has shown that proteins produced by the two genes, known as PINK1 and Parkin, are required to prevent cells from being detected and attacked by the immune system.

Classified as: genetics, mitochondria, Parkinson's, Parkinson's disease, autoimmune disease, PINK1, Parkin
Published on: 27 Jun 2016

The results of their study, published in the journal Movement Disorders, could also have a major impact on the quality of research on Parkinson’s disease.

Classified as: treatment, Parkinson's, Neurology, diagnosis, Parkinson's disease, International Parkinson and Movement Disorder Society, MDS, Ron Postuma, Daniela Berg, health and lifestyle
Published on: 13 Nov 2015

Millions of Canadians are affected by diseases of the brain such as ALS, Parkinson’s and brain tumours, for which there are limited treatments and no cures. By 2020, neurological conditions will become the leading cause of death and disability.

Classified as: Parkinson's, stem cells, induced pluripotent stem cells, iPSCs, neuron, skin cells
Category:
Published on: 2 Apr 2015

The Montreal Neurological Institute and Hospital - The Neuro, McGill University and the McGill University Health Centre, is at the forefront of Parkinson’s research and clinical care. Parkinson’s patients are seen at The Neuro’s Movement Disorders Clinic and the Montreal General Hospital. Approximately 100,000 Canadians have Parkinson’s disease.

The Neuro to introduce experimental drug treatment

Classified as: neuroscience, brain, Parkinson's, neurological disease, Montreal Neurological Institute and Hospital, mcgill faculty of medicine research
Category:
Published on: 2 Apr 2015

The Montreal Neurological Institute and Hospital - The Neuro, McGill University and the McGill University Health Centre, is at the forefront of Parkinson’s research and clinical care. Parkinson’s patients are seen at The Neuro’s Movement Disorders Clinic and the Montreal General Hospital. Approximately 100,000 Canadians have Parkinson’s disease.  

New Rapid-Access Clinic at The Neuro reduces wait time

Classified as: neuroscience, brain, Parkinson's, Neurology, neurodegenerative diseases
Category:
Published on: 31 Mar 2014

Scientists from the Montreal Neurological Institute and Hospital in Canada have discovered that two genes linked to hereditary Parkinson’s disease are involved in the early-stage quality control of mitochondria. The protective mechanism, which is reported in The EMBO Journal, removes damaged proteins that arise from oxidative stress from mitochondria. 

Classified as: neuroscience, brain, medicine, Parkinson's, Neuro, Neurology, Ted Fon
Category:
Published on: 21 Jan 2014

Research opens door to new drug therapies for Parkinson’s disease

Classified as: brain, genetic, mitochondria, Parkinson's, neurological disease, McGill, drugs, Ted Fon, Montreal Neurological Institute and Hospital, Kalle Gehring, protein
Category:
Published on: 9 May 2013

What is Parkinson’s Disease?

Classified as: neuroscience, brain, treatment, Research, Parkinson's
Category:
Published on: 4 Apr 2013

November 27, 2012 - Clinician-scientists take a unique, integrated approach that is essential to advancing science and medicine. Problems encountered in the clinic inspire research and new findings from the labs are directly applied to patients’ needs. The integrated model is a hallmark of the Montreal Neurological Institute and Hospital – The Neuro, at McGill University and the MUHC and is now being replicated worldwide. Two clinician-scientists at The Neuro have been awarded grants today to further research on Parkinson’s disease and HIV/AIDS.

Classified as: neuroscience, Parkinson's, CIHR, funding, neurological disorders, HIV, Neuro, AIDS, Lesley Fellows, Neurology, Ted Fon
Category:
Published on: 5 Feb 2013

International study with researchers at The Neuro reveals links with other neurodegenerative diseases

MONTREAL, October 9, 2012  - Scientists at the Montreal Neurological Institute and Hospital – The Neuro,  McGill University working with a team at Oxford University have uncovered the genetic defect underlying a group of rare genetic disorders. 

Classified as: adult, Alzheimer's, chiild, Gene, genetic, infant, mitochondria, mutation, neurological, Parkinson's, rare disorders
Category:
Published on: 9 Oct 2012